Here’s what you should know.
1. A group of angel investors supplemented funding Orthokina received from a Biomedical Catalyst award and an Industrial Challenge award.
2. Orthonika will use the funding to accelerate the implant’s biomechanical testing and to carry out a pre-clinical pilot trial.
3. Orthonika Co-Founder and CEO Mario Alberto Accardi, PhD, said in a release, “This investment demonstrates a strong endorsement of our progress in developing a novel solution for meniscus injury and allows us to cement our network of collaborators and suppliers.”
More articles on orthopedics:
Return to play, patient satisfaction high in active athletes after ACL reconstruction — 5 study insights
Dr. Jeffrey Dugas performs surgery on WWE star Braum Strowman: 4 key notes
University of Pennsylvania, Children’s Hospital of Philadelphia to study youth concussions: 5 things to know
